Hikma Pharmaceuticals Regulatory News (HIK)

1.

Name of the issuer

HIKMA PHARMACEUTICALS PLC

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

(i)

3.

Name of person discharging managerial

responsibilities/director

BASSAM KANAAN

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest 1

3 ABOVE

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

ORDINARY SHARES OF 10P EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

BASSAM KANAAN

8.

State the nature of the transaction

SALE OF 30,000 NIL-COST SHARE AWARDS UNDER THE TERMS OF THE 2006 LONG TERM INCENTIVE PLAN UPON VESTING

AND

EXERCISE OF 43,582 ORDINARY SHARES AT $0.9075 PER SHARE UNDER THE TERMS OF THE 2004 STOCK OPTION PLAN

9.

Number of shares, debentures or financial

instruments relating to shares acquired

N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A

11.

Number of shares, debentures or financial

instruments relating to shares disposed

30,000 (LTIP)

43,582 (STOCK OPTIONS)

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

0.0038%

13.

Price per share or value of transaction

£6.4268998 (LTIP)

£6.35 (for 13,582 STOCK OPTIONS)

£6.36 (for 30,000 STOCK OPTIONS)

14.

Date and place of transaction

22 APRIL 2010, LONDON (LTIP AND 13,582 OF STOCK OPTIONS)

23 APRIL (30,000 STOCK OPTIONS)

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

89,222 (0.046%)

16.

Date issuer informed of transaction

23 APRIL 2010

17.

Date of grant

N/A

18.

Period during which or date on which exercisable

 N/A

19.

Total amount paid (if any) for grant of the option

N/A

20.

Description of shares or debentures involved (class and number)

N/A

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise

N/A

22.

Total number of shares or debentures over which options held following notification

N/A

23.

Any additional information

N/A

24.

Name of contact and telephone number for queries

Mark Duckworth 0207 399 2766

Name of authorised official of issuer responsible for making notification

Henry Knowles

Date of notification 23 April 2010

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.